Longjin pharmaceutical co.
002750
80.66
0
中
EN
LINK
NMPA
MUYA AGRI-TECH
LONGJIN BIO-TECH
Shanghai Rouyishi BIO-TECH
YUNNAN MPA
About Longjin
Product & business
Science & Technology
News
Careers
Investors
Longjin Profile
Longjin History
Longjin's Mission &Vision
Longjin's Core Vlues
Responsibilities
Recognitions
Founder's Message
Medicines
HEMP
Natural Plant Extracts
Prospective Study
R&D Achievements
Smart Manufacturing
Whole Industry Chain
Notifications
Company News
LONGJIN IN Media
Longjin Culture
Grow With Us
Work At Longjin
Job Openings
Governance
Development Strategy
STOCK INFORMATION
Investor Services
NEWS
通知公示
龙津动态
媒体报道
注射用灯盏花素治疗急性脑梗死和冠心病心绞痛的临床综合评价
DATE：2023.11.22 SOURCE：原创 VIEW：965
题目：注射用灯盏花素治疗急性脑梗死和冠心病心绞痛的临床综合评价
刘 毅，耿洪娇，崔 鑫，张旭明
*
，谢雁鸣
*
中国中医科学院 中医临床基础医学研究所，北京
100700
PREV：
注射用灯盏花素治疗脑梗死的药物经济学评价
NEXT：
注射用灯盏花素临床应用专家共识发布
